Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-18 / Case Rep Med 2016;2016:9639585Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2016-07-12 / Cytotherapy 2016 09;18(9):1178-86A Perspective of Immunotherapy for Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2016-07-07 / Cancers (Basel) 2016 Jul;8(7)PD-1 blockade enhances the vaccination-induced immune response in glioma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2016-07-07 / JCI Insight 2016 Jul;1(10)Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-01 / Oncoimmunology 2017;6(9):e1207032Immunological Aspects of Malignant Gliomas
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-07-01 / Can J Neurol Sci 2016 Jul;43(4):494-502NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2016-06-29 / J. Immunol. 2016 08;197(3):795-806HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer
/in Dendritic Cells, International Publications /von 2016-06-27 / Cell. Mol. Immunol. 2018 02;15(2):135-145Dendritic cell vaccination in melanoma patients: From promising results to future perspectives
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-20 / Hum Vaccin Immunother 2016 10;12(10):2523-2528
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de